Skip to main content
SpringerLink
Log in

Contents and Formulations of Platelet Rich Plasma

  • Chapter
  • First Online:
Platelet Rich Plasma in Musculoskeletal Practice

Abstract

Multiple studies have demonstrated a role for platelet-rich plasma (PRP) in accelerating and facilitating response to injury. The cellular response to injury progresses through four general stages: hemostasis, inflammation, proliferation, and finally remodeling. Each phase is characterized by enhanced cellular or molecular activity, all of which involve platelets. Blood plasma and platelets are responsible for hemostasis, while leukocytes and activated platelets mediate inflammation, and growth factors derived from platelet α-granules influence tissue regeneration. Specifically, the leukocyte content of PRP is thought influence the inflammatory phase, while angiogenic and mitogenic growth factor concentrations are believed to aid tissue regeneration [1]. Both the precise composition and formulation of PRP affect the cellular environment in which it is placed and determine its overall effect on tissue repair.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Rozman P, Bolta Z. Use of platelet growth factors in treating wounds and soft-tissue injuries. Acta Dermatoven APA. 2007;16(4):156–65.

    CAS  Google Scholar 

  2. Rehfeldt F, Engler AJ, Eckhardt A, Ahmed F, Discher DE. Cell responses to the mechanochemical microenvironment – implications for regenerative medicine and drug delivery. Adv Drug Deliv Rev. 2007;59(13):1329–39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009;37(11):2259–72.

    Article  PubMed  Google Scholar 

  4. Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001;10(4):225–8.

    Article  CAS  PubMed  Google Scholar 

  5. Creaney L, Hamilton B. Growth factor delivery methods in the management of sports injuries: the state of play. Br J Sports Med. 2008;42(5):314–20.

    Article  CAS  PubMed  Google Scholar 

  6. Anitua E, Sanchez M, Zalduendo MM, de la Fuente M, Prado R, Orive G, et al. Fibroblastic response to treatment with different preparations rich in growth factors. Cell Prolif. 2009;42(2):162–70.

    Article  CAS  PubMed  Google Scholar 

  7. Sundman EA, Cole BJ, Fortier LA. Growth Factor and Catabolic Cytokine Concentrations Are Influenced by the Cellular Composition of Platelet-Rich Plasma. Am J Sports Med. 2011;39(10):2135–40.

    Google Scholar 

  8. de Jonge S, de Vos RJ, Weir A, van Schie HT, Bierma-Zeinstra SM, Verhaar JA, et al. One-year follow-up of platelet-rich plasma treatment in chronic Achilles tendinopathy: a double-blind randomized placebo-controlled trial. Am J Sports Med. [Research Support, Non-U.S. Gov’t]. 2011;39(8):1623–9.

    Google Scholar 

  9. Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. The American journal of sports medicine. [Randomized Controlled Trial Research Support, Non-U.S. Gov’t]. 2010;38(2):255–62.

    Google Scholar 

  10. Zimmermann R, Jakubietz R, Jakubietz M, Strasser E, Schlegel A, Wiltfang J, et al. Different preparation methods to obtain platelet components as a source of growth factors for local application. Transfusion. 2001;41(10):1217–24.

    Article  CAS  PubMed  Google Scholar 

  11. Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg. 2004;114(6):1502–8.

    Article  PubMed  Google Scholar 

  12. Araki J, Jona M, Suga H, Eto H, Kato H, Aoi N, et al. Optimized preparation method of platelet-concentrated plasma (PCP) and non-coagulating platelet-derived factor concentrates (PFC): maximization of platelet concentration and removal of fibrinogen. Tissue Eng Part C Methods. 2012;18(3):176–85.

    Google Scholar 

  13. Haynesworth SE, Kadiyala S, Liang LN. Mitogenic stimulation of human mesenchymal stem cells by platelet release suggest a mechanism for enhancement of bone repair by platelet concentrates. 48th meeting of the Orthopedic Research Society. Boston; 2002.

    Google Scholar 

  14. Lui Y, Kalen A, Risto O. Fibroblast proliferation due to exposure to a platelet concentrate in vitro is pH dependent. Wound Repair Regen. 2002;10(336).

    Google Scholar 

  15. Mastrangelo AN, Vavken P, Fleming BC, Harrison SL, Murray MM. Reduced platelet concentration does not harm PRP effectiveness for ACL repair in a porcine in vivo model. J Orthop Res Off Publ Orthop Res Soc. [Research Support, N.I.H., Extramural]. 2011;29(7):1002–7.

    Google Scholar 

  16. Yamaguchi R, Terashima H, Yoneyama S, Tadano S, Ohkohchi N. Effects of platelet-rich plasma on intestinal anastomotic healing in rats: PRP concentration is a key factor. J Surg Res. 2010;2.

    Google Scholar 

  17. Freeman MR, Schneck FX, Gagnon ML, Corless C, Soker S, Niknejad K, et al. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res. 1995;55(18):4140–5.

    CAS  PubMed  Google Scholar 

  18. Nielsen HJ, Werther K, Mynster T, Brunner N. Soluble vascular endothelial growth factor in various blood transfusion components. Transfusion. 1999;39(10):1078–83.

    Article  CAS  PubMed  Google Scholar 

  19. McCarrel T, Fortier L. Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression. J Orthop Res. 2009;27(8):1033–42.

    Article  CAS  PubMed  Google Scholar 

  20. Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 2003;5(14):1317–27.

    Article  CAS  PubMed  Google Scholar 

  21. Khalafi RS, Bradford DW, Wilson MG. Topical application of autologous blood products during surgical closure following a coronary artery bypass graft. Eur J Cardiothorac Surg. 2008;34(2):360–4.

    Article  PubMed  Google Scholar 

  22. Everts PA, Devilee RJ, Brown Mahoney C, van Erp A, Oosterbos CJ, Stellenboom M, et al. Exogenous application of platelet-leukocyte gel during open subacromial decompression contributes to improved patient outcome. A prospective randomized double- blind study. Eur Surg Res. 2008;40(2):203–10.

    Article  CAS  PubMed  Google Scholar 

  23. Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med. 2006;34(11):1774–8.

    Article  PubMed  Google Scholar 

  24. Laurens N, Koolwijk P, de Maat MP. Fibrin structure and wound healing. J Thromb Haemost. 2006;4(5):932–9.

    Article  CAS  PubMed  Google Scholar 

  25. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L- PRF). Trends Biotechnol. 2009;27(3):158–67.

    Article  CAS  PubMed  Google Scholar 

  26. Flick MJ, Du X, Degen JL. Fibrin(ogen)-alpha M beta 2 interactions regulate leukocyte function and innate immunity in vivo. Exp Biol Med (Maywood). 2004;229(11):1105–10.

    CAS  Google Scholar 

  27. de Maat MP, Verschuur M. Fibrinogen heterogeneity: inherited and noninherited. Curr Opin Hematol. 2005;12(5):377–83.

    Article  PubMed  Google Scholar 

  28. Clark RA. Fibrin and wound healing. Ann N Y Acad Sci. 2001;936:355–67.

    Article  CAS  PubMed  Google Scholar 

  29. van Hinsbergh VW, Collen A, Koolwijk P. Role of fibrin matrix in angiogenesis. Ann N Y Acad Sci. 2001;936:426–37.

    Article  PubMed  Google Scholar 

  30. Doessing S, Holm L, Heinemeier KM, Feldt-Rasmussen U, Schjerling P, Qvortrup K, et al. GH and IGF1 levels are positively associated with musculotendinous collagen expression: experiments in acromegalic and GH deficiency patients. Eur J Endocrinol. 2010;163(6):853–62.

    Google Scholar 

  31. Gustafsson T, Kraus WE. Exercise-induced angiogenesis-related growth and transcription factors in skeletal muscle, and their modification in muscle pathology. Front Biosci. [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S. Review]. 2001;6:D75–89.

    Google Scholar 

  32. Sanchez M, Azofra J, Anitua E, Andia I, Padilla S, Santisteban J, et al. Plasma rich in growth factors to treat an articular cartilage avulsion: a case report. Med Sci Sports Exerc. 2003;35(10):1648–52.

    Article  PubMed  Google Scholar 

  33. Banfi G, Corsi MM, Volpi P. Could platelet rich plasma have effects on systemic circulating growth factors and cytokine release in orthopaedic applications? Br J Sports Med. [Editorial]. 2006;40(10):816.

    Google Scholar 

  34. Ljungqvist A, Schwellnus MP, Bachl N, Collins M, Cook J, Khan KM, et al. International Olympic Committee consensus statement: molecular basis of connective tissue and muscle injuries in sport. Clin Sports Med. [Consensus Development Conference]. 2008;27(1):231–9, x–xi.

    Google Scholar 

  35. WADA Laboratory Committee. Decision Limits for the Confirmatory Quantification of Threshold Substances; 2009 Sep 15. Document Number: TD2009DL. Version: 1.0.

    Google Scholar 

  36. Kniess A, Ziegler E, Kratzsch J, Thieme D, Muller RK. Potential parameters for the detection of hGH doping. Anal Bioanal Chem. [Clinical Trial Comparative Study Controlled Clinical Trial Evaluation Studies Research Support, Non-U.S. Gov’t]. 2003;376(5):696–700.

    Google Scholar 

  37. Anitua E, Andia I, Sanchez M, Azofra J, del Mar Zalduendo M, de la Fuente M, et al. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res. 2005;23(2):281–6.

    Article  CAS  PubMed  Google Scholar 

  38. Juul A, Scheike T, Pedersen AT, Main KM, Andersson AM, Pedersen LM, et al. Changes in serum concentrations of growth hormone, insulin, insulin-like growth factor and insulin-like growth factor-binding proteins 1 and 3 and urinary growth hormone excretion during the menstrual cycle. Hum Reprod. [Research Support, Non-U.S. Gov’t]. 1997;12(10):2123–8.

    Google Scholar 

  39. de Mos M, van der Windt AE, Jahr H, van Schie HT, Weinans H, Verhaar JA, et al. Can platelet-rich plasma enhance tendon repair? A cell culture study. Am J Sports Med. 2008;36(6):1171–8.

    Article  PubMed  Google Scholar 

  40. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2004;91(1):4–15.

    CAS  PubMed  Google Scholar 

  41. Min JK, Lee YM, Kim JH, Kim YM, Kim SW, Lee SY, et al. Hepatocyte growth factor suppresses vascular endothelial growth factor-induced expression of endothelial ICAM-1 and VCAM-1 by inhibiting the nuclear factor-kappaB pathway. Circ Res. 2005;96(3):300–7.

    Article  CAS  PubMed  Google Scholar 

  42. He L, Lin Y, Hu X, Zhang Y, Wu H. A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108(5):707–13.

    Article  PubMed  Google Scholar 

  43. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85(6):638–46.

    Article  CAS  PubMed  Google Scholar 

  44. Weibrich G, Kleis WK, Hafner G, Hitzler WE. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg. 2002;30(2):97–102.

    Article  PubMed  Google Scholar 

  45. Castillo TN, Pouliot MA, Kim HJ, Dragoo JL. Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems. Am J Sports Med. 2011;39(2):266–71.

    Article  PubMed  Google Scholar 

  46. Dragoo JL, Braun HJ, Durham JL, Ridley BA, Odegaard JI, Luong R, Arnoczky SP. Comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in healthy rabbit tendons. Am J Sports Med. 2012 Jun;40(6):1274–81. doi: 10.1177/0363546512442334. Epub 2012 Apr 10. PMID: 22495144.

    Google Scholar 

  47. Felisaz N, Boumediene K, Ghayor C, Herrouin JF, Bogdanowicz P, Galerra P, et al. Stimulating effect of diacerein on TGF-beta1 and beta2 expression in articular chondrocytes cultured with and without interleukin-1. Osteoarthritis Cartilage. 1999;7(3):255–64.

    Article  CAS  PubMed  Google Scholar 

  48. Roman-Blas JA, Stokes DG, Jimenez SA. Modulation of TGF-beta signaling by proinflammatory cytokines in articular chondrocytes. Osteoarthritis Cartilage. 2007;15(12):1367–77.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants. 1999;14(4):529–35.

    CAS  PubMed  Google Scholar 

  50. Weibrich G, Kleis WK, Hitzler WE, Hafner G. Comparison of the platelet concentrate collection system with the plasma-rich-in-growth-factors kit to produce platelet-rich plasma: a technical report. Int J Oral Maxillofac Implants. 2005;20(1):118–23.

    PubMed  Google Scholar 

  51. Pietrzak WS, An YH, Kang QK, Demos HA, Ehrens KH. Platelet-rich and platelet- poor plasma: development of an animal model to evaluate hemostatic efficacy. J Craniofac Surg. 2007;18(3):559–67.

    Article  PubMed  Google Scholar 

  52. Mazzucco L, Balbo V, Cattana E, Guaschino R, Borzini P. Not every PRP-gel is born equal. Evaluation of growth factor availability for tissues through four PRP-gel preparations: Fibrinet, RegenPRP-Kit, Plateltex and one manual procedure. Vox Sang. 2009;97(2):110–8.

    Article  CAS  PubMed  Google Scholar 

  53. Anitua E, Sanchez M, Nurden AT, Zalduendo M, de la Fuente M, Orive G, et al. Autologous fibrin matrices: a potential source of biological mediators that modulate tendon cell activities. J Biomed Mat Res Part A. [Evaluation Studies Research Support, Non-U.S. Gov’t]. 2006;77(2):285–93.

    Google Scholar 

  54. Brass LF. Thrombin and platelet activation. Chest. 2003;124(3 Suppl):18S–25.

    Article  CAS  PubMed  Google Scholar 

  55. Roussy Y, Bertrand Duchesne MP, Gagnon G. Activation of human platelet-rich plasmas: effect on growth factors release, cell division and in vivo bone formation. Clin Oral Implants Res. [Research Support, Non-U.S. Gov’t]. 2007;18(5):639–48.

    Google Scholar 

  56. Harrison S, Vavken P, Kevy S, Jacobson M, Zurakowski D, Murray MM. Platelet activation by collagen provides sustained release of anabolic cytokines. Am J Sports Med. 2011;39(4):729–34.

    Google Scholar 

  57. Anitua E, Alkhraisat MH, Orive G. Perspectives and challenges in regenerative medicine using plasma rich in growth factors. J Control Release. 2011;8.

    Google Scholar 

  58. Cognasse F, Hamzeh-Cognasse H, Lafarge S, Acquart S, Chavarin P, Courbil R, et al. Donor platelets stored for at least 3 days can elicit activation marker expression by the recipient’s blood mononuclear cells: an in vitro study. Transfusion. 2009;49(1):91–8.

    Article  PubMed  Google Scholar 

  59. Hartley PS, Savill J, Brown SB. The death of human platelets during incubation in citrated plasma involves shedding of CD42b and aggregation of dead platelets. Thromb Haemost. 2006;95(1):100–6.

    CAS  PubMed  Google Scholar 

  60. Landi EP, Roveri EG, Ozelo MC, Annichino-Bizzacchi JM, Origa AF, de Carvalho Reis AR, et al. Effects of high platelet concentration in collecting and freezing dry platelets concentrates. Transfus Apher Sci. 2004;30(3):205–12.

    Google Scholar 

  61. Johnson LN, Winter KM, Reid S, Hartkopf-Theis T, Marks DC. Cryopreservation of buffy-coat-derived platelet concentrates in dimethyl sulfoxide and platelet additive solution. Cryobiology. 2011;62(2):100–6.

    Google Scholar 

  62. Farndale RW, Siljander PR, Onley DJ, Sundaresan P, Knight CG, Barnes MJ. Collagen-platelet interactions: recognition and signalling. Biochem Soc Symp. 2003;(70):81–94.

    Google Scholar 

  63. Fufa D, Shealy B, Jacobson M, Kevy S, Murray MM. Activation of platelet-rich plasma using soluble type I collagen. J Oral Maxillofac Surg. [Comparative Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, Non-P.H.S.]. 2008;66(4):684–90.

    Google Scholar 

  64. Zhang J, Wang JH. Platelet-rich plasma releasate promotes differentiation of tendon stem cells into active tenocytes. Am J Sports Med. 2010;38(12):2477–86.

    Google Scholar 

  65. Fallouh L, Nakagawa K, Sasho T, Arai M, Kitahara S, Wada Y, et al. Effects of autologous platelet-rich plasma on cell viability and collagen synthesis in injured human anterior cruciate ligament. J Bone Joint Surg Am. 2010;92(18):2909–16.

    Google Scholar 

  66. Leitner GC, Gruber R, Neumuller J, Wagner A, Kloimstein P, Hocker P, et al. Platelet content and growth factor release in platelet-rich plasma: a comparison of four different systems. Vox Sang. [Comparative Study Evaluation Studies]. 2006;91(2):135–9.

    Google Scholar 

  67. Kevy SV, Jacobson MS. Comparison of methods for point of care preparation of autologous platelet gel. J Extra Corpor Technol. [Comparative Study In Vitro Research Support, Non-U.S. Gov’t]. 2004;36(1):28–35.

    Google Scholar 

  68. Woodell-May JE, Ridderman DN, Swift MJ, Higgins J. Producing accurate platelet counts for platelet rich plasma: validation of a hematology analyzer and preparation techniques for counting. J Craniofac Surg. 2005;16:749–56; discussion 57–9.

    Article  PubMed  Google Scholar 

  69. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. [Review]. 2004;62(4):489–96.

    Google Scholar 

  70. DeLong JM, Russell RP, Mazzocca AD. Platelet-rich plasma: the PAW classification system. Arthroscopy. 2012;28(7):998–1009.

    Article  PubMed  Google Scholar 

  71. Mishra A, Harmon K, Woodall J, Vieira A. Sports medicine applications of platelet rich plasma. Curr Pharm Biotechnol. 2012;13(7):1185–95.

    Article  CAS  PubMed  Google Scholar 

  72. Kochan A, Scarpone M, Mandle R. Platelet rich plasma preparation: a comparison of the harvest SmartPReP 2 APC+ with the arteriocyte magellan. AAOS.org. 2009. http://orthodoc.aaos.org/WilliamFBennettMD/Comparison%20of%20SmartPReP%202%20and%20Arteriocyte%20Magellan.pdf.

  73. http://www.perfusion.com/perfusion/prpdevicesummary.asp. Accessed 9 Apr 2013.

  74. Mandle. Analysis of EmCyte Corporation Concentrating Systems. An independent review of pre-clinical performance data. http://www.emcyte.com/articles/PerformanceData.pdf.

  75. Sánchez M, Anitua E, Azofra J, Andía I, Padilla S, Mujika I. Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. Am J Sports Med. 2007;35(2):245–51.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopaedic Surgery, Stanford University, Stanford, CA, USA

    Amy S. Wasterlain MD, Hillary J. Braun MD & Jason L. Dragoo MD

Authors
  1. Amy S. Wasterlain MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hillary J. Braun MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jason L. Dragoo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jason L. Dragoo MD .

Editor information

Editors and Affiliations

  1. Department of Musculoskeletal Disorders Faculty of Medicine, Surgery and Dentistry, University of Salerno, Salerno, Italy

    Nicola Maffulli

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag London

About this chapter

Cite this chapter

Wasterlain, A.S., Braun, H.J., Dragoo, J.L. (2016). Contents and Formulations of Platelet Rich Plasma. In: Maffulli, N. (eds) Platelet Rich Plasma in Musculoskeletal Practice. Springer, London. https://doi.org/10.1007/978-1-4471-7271-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-7271-0_1

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-7270-3

  • Online ISBN: 978-1-4471-7271-0

  • eBook Packages: Medicine

Publish with us

Policies and ethics

Search

Navigation